Revive Therapeutics Eulerpool Uudised

Revive Therapeutics aktsia uudised

Revive Therapeutics jälgivad paljud ajakirjanikud ja investorid üle kogu maailma. Kõige värskemad Revive Therapeutics uudised paneme siia kokku.

• 26. juuni ·

  Yahoo
  Revive Therapeutics Nears Completion of Nerve Agent Countermeasure Study with Canadian DND
• 26. juuni ·

  Yahoo
  Revive Therapeutics Nears Completion of Key Nerve Agent Countermeasure Study with Canadian Department of National Defence Highlighting Significant Stockpiling Opportunity
• 4. juuni ·

  Yahoo
  Revive Therapeutics Advances with Next-Generation Bucillamine Development
• 3. märts ·

  Yahoo
  Revive Therapeutics Announces LOI to Acquire DiagnaMed’s Molecular Hydrogen Program
• 3. veebruar ·

  Yahoo
  Revive Therapeutics Announces Update on R&D Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
• 8. jaanuar ·

  Yahoo
  Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
• 12. november ·

  Yahoo
  Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke
• 31. oktoober ·

  Yahoo
  Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
• 18. september ·

  Yahoo
  Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
• 28. august ·

  Yahoo
  Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure and Expansion into Viral Infections